We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EML:NASDAQEastern Company (The) Analysis

Data as of 2026-03-31 - not real-time

$19.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above its 20‑day SMA, which sits above the 50‑day SMA but remains below the 200‑day SMA, indicating short‑term strength within a longer‑term downtrend. Momentum is flat, with the RSI hovering near the midpoint and the MACD histogram turning negative, signaling a bearish tilt. Volume has been slipping, adding pressure to the price action. The market respects a support zone in the high‑teens and a resistance ceiling in the low‑twenties, placing the price in a tight range. Volatility is elevated, while beta is comfortably below one, suggesting limited correlation with broader market moves. Overall, the technical picture is neutral to slightly bearish, with downside bias from weakening momentum.
Fundamentally, revenue contracted by double digits year‑over‑year, and margins sit in the low‑20s for gross and single‑digit territory for operating profit. The company trades at a forward PE well below the industry average and a price‑to‑book under one, implying a valuation discount. Free cash flow remains positive and the dividend yield exceeds two percent, backed by a payout ratio under half of earnings, supporting dividend sustainability. Debt levels are moderate, with a debt‑to‑equity ratio in the low‑forties percent range, and cash on hand is modest but sufficient to cover near‑term obligations. Management highlighted a leaner cost structure, signs of demand stabilization for 2026, and a strengthening balance sheet during the recent earnings call. Recent insider purchases, albeit small, add a modest confidence signal, making the stock a potential value‑oriented play for investors comfortable with short‑term volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram
  • Decreasing volume trend
  • Price confined between support and resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Management guidance on demand stabilization
  • Undervalued valuation multiples
  • Sustainable dividend yield

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low beta and defensive profile
  • Value‑oriented valuation discount
  • Consistent dividend with sustainable payout

Key Metrics & Analysis

Financial Health

Revenue Growth-13.70%
Profit Margin2.86%
P/E Ratio20.4
ROE4.86%
ROA3.65%
Debt/Equity43.21
P/B Ratio1.0
Op. Cash Flow$8.9M
Free Cash Flow$3.4M
Industry P/E28.1

Technical Analysis

TrendNeutral
RSI53.4
Support$17.66
Resistance$21.45
MA 20$19.88
MA 50$19.05
MA 200$21.17
MACDBearish
VolumeDecreasing
Fear & Greed Index72.23

Valuation

GradeUndervalued
TypeValue
Dividend Yield2.21%

Risk Assessment

Beta0.65
Volatility34.00%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.